Navigation Links
ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection)
Date:5/15/2008

ar(4).

NSCLC is defined as a group of histologies, that is, tumor types differentiated by cellular structure. The most common NSCLC histology types are squamous (or epidermoid) carcinoma, adenocarcinoma, and large cell carcinoma. These histologies are often classified together because to date, approaches to diagnosis, staging, prognosis and treatment have been similar(5).

About Lilly Oncology, a Division of Eli Lilly and Company

For more than four decades, Lilly Oncology has been dedicated to delivering innovative solutions that improve the care of people living with cancer. Because no two cancer patients are alike, Lilly Oncology is committed to developing novel treatment approaches. Our quest is to develop a broad portfolio of tailored therapies that accelerate the pace and progress of cancer care.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers -- through medicines and information -- for some of the world's most urgent medical needs.

ALIMTA(R) (pemetrexed for injection), Lilly

P-LLY

This press release contains forward-looking statements about the potential of ALIMTA for the treatment of non-small cell lung cancer and reflects Lilly's current beliefs. However, as with any pharmaceutical product under development, there are substantial risks and uncertainties in the process of development, commercialization, and regulatory review. There is no guarantee that the product will receive additional regulatory approvals. There is also no guarantee that the product will continue to be commercially successful. For further discussion of these and other risks and uncertainties, see Lilly's filings with the United
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Study suggests blood test can help improve treatment outcomes for breast cancer patients
2. Study takes a step toward better defining fatigue
3. Having Less Power Impairs the Mind and Ability to Get Ahead, Study Shows
4. Study finds parents use cough medicines on under-2s despite the warnings
5. CardioDynamics Announces Significant ICG Study with Nearly Three Times the National Average Blood Pressure Control Rates at the American Society for Hypertension Annual Scientific Meeting
6. Study Supports Popular HIV Drug Regimen
7. Duska Therapeutics Sponsored University of Pennsylvania Study Demonstrates ATP Improves Sperm Motility and In Vitro Fertilization in Animals
8. Study shows that prostate cancer increases the risk of bone fracture
9. Study Suggests Green Tea May Support the Medical Treatment of Stomach and Colon Cancer
10. Forty-Five Percent of U.S. Employees Have Gained Weight at Their Current Jobs, CareerBuilder.com Study Finds
11. New Study: Texas Seniors 4th Hardest-Hit from Proposed Bush Administration Medicare Cuts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...partment of Defense and Federal Agencies in, the ...olden Phoenix is a, four-day, multi-agency colla...l, state and local agencies with large and complex...ding a vital, ad-hoc, secure mobile communicatio...ise., NORFOLK, Va., July 25 /PRNewswire/ -- Datal...
(Date:7/25/2008).../ -- The Elekta Family of Companies will,showcase ... the 2008,American Association of Physicists in Me...e joint forces of Elekta, IMPAC and CMS are delive...elivery solutions that,streamline the treatment pr...as well as enhance clinician efficiency., "Our re...
(Date:7/25/2008)...ogram delivers immediate cost savings for http://...ss to language interpreters] to firms switching l...s. , Washington, D.C. (V...e-inc.com/index.html [(Language Learning Enterpri... translation, and language instruction services to...
(Date:7/25/2008)...us-based law firm represents Pickerington man who ...olumbus-area Kroger store , ...http://www.donaheyohioinjurylawyers.com [The Dona...law firms in central Ohio, has filed a product lia...08CV9804) against The Kroger Co., in connection wi...
Breaking Medicine News(10 mins):Health News:Dataline Announces Participation in Operation Golden Phoenix 2Health News:Dataline Announces Participation in Operation Golden Phoenix 3Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3Health News:Donahey Law Firm Files E. Coli Product Liability Lawsuit Against Kroger Company in Franklin County Court 2
... between Hewlett Packard and the government in Nor...r prescriptions towards the implementation// of an...lth Social Services and Public Safety has announce...ern Ireland will be equipped with an electronic sy...
...ll have a new medical college from the next academ...ednesday that the proposed medical college will be...n addition to the new campus of the Rajiv Gandhi U... said, "The revenue department will identify alter...
...has revealed that those who drink coffee very rare...heavy drinkers.// According to a study in the Sep...ple could get a heart attack within one hour of ha...k of almost 60% amongst moderate coffee drinkers, ...
..."Pascal" Norris, who died in July, is thought to b...an two decades in Scotland. NHS Borders revealed t...ied on 8 July in Edinburgh Royal Infirmary and lat...died of anthrax. Health Protection Scotland said ...
Other Medicine News:
(Date:7/23/2008)... Protein Therapeutics that Modulate Alte...Mass., July 23 /- Taligen Therapeutic...e growth plan with the,appointment of Abbie Celnik...blishment of its headquarters in Cambridge, Mass. ...ounder of the company who remains president., Und...
(Date:7/22/2008)...ent Initiative bring MJFF,s,current active industr...2009, NEW YORK, July 22 /PRNewswire-USNewswire/ -...sformative treatments and a cure for Parkinson,s,d...n,s Research has awarded,$2.7 million in total fun...re granted under MJFF,s Therapeutics Development I...
(Date:7/22/2008)...a(R) Resulted in Significant, Reductions in A1C in...ithm Used, BRIDG... the "Adjust to,Target in Type 2 Diabetes: Compari... for Adjustment of Mealtime Insulin Glulisine" stu...ation,s (ADA) medical journal,Diabetes Care. This...
(Date:7/22/2008)...ersity Medical Center Based on Rosetta G...st Differentiates Squamous From Non-Squamous Non-S...us-Cell Carcinoma of the Lung With Sensitiv...is is the First CLIA Approved Test Which Leverages... Accurate Diagnosis of Lung Cancer, REHOVOT, Isra...
Breaking Medicine Technology:Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 3Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 2Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 3Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5Hip replacement improves function saves money at any age 21969 1Hip replacement improves function saves money at any age 21969 2LIAI researchers discover new cellular mechanism that will significantly advance vaccine development 3650 1LIAI researchers discover new cellular mechanism that will significantly advance vaccine development 3650 2Menstruation Cessation in Female Teen Athletes May Be Caused by Hormone 21964 1Menstruation Cessation in Female Teen Athletes May Be Caused by Hormone 21964 2Foundation Radiology Group and Cherry Tree Medical Associates Sign Multi Year Contract for Diagnostic Services 21961 1Foundation Radiology Group and Cherry Tree Medical Associates Sign Multi Year Contract for Diagnostic Services 21961 2
... patients taking,once-daily Lialda remained relaps...May 22, 2007 /PRNewswire-FirstCall/ -- A,long-term... (303),presented at the British Society of Gastroe...rch 2007 showed Shire plc,s,Lialda(mesalamine) is ...day, secondary endpoints of study 303 were present...
... Doses, According to,New Data Presented at Digesti...wswire/ -- UCB announced today that,new data prese...ated long-term response and remission in Crohn,s d...pegol), the only Fc-free,PEGylated, Fab, fragment ... long-term open label,continuation of the Phase II...
Other Medicine Technology:Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 2Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 3Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 4Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 5Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 6Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 7Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term,Safety Study of Lialda (mesalamine) Presented at DDW 8UCB Presents Long-Term CImzia Data in Crohn's Disease 2UCB Presents Long-Term CImzia Data in Crohn's Disease 3UCB Presents Long-Term CImzia Data in Crohn's Disease 4UCB Presents Long-Term CImzia Data in Crohn's Disease 5
Delicate curved shafts with light crisscross serrations. Serrated handle with polished finish. Most popular size or model.
Delicate cross serrated lightly curved tips with serrated handle and polished finish. Most popular size or model.
Delicate lightly curved tips, 1 x 2 mouse style teeth. Serrated handle with polished finish.
Straight tubular shaft with delicate 1.5 mm oval jaws. Squeeze barrel style handle with tip guard and polished finish.
Medicine Products: